HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Coty Continues Licensing Spree With Etro; CEO Nabi Shares Prestige Fragrance Vision

Executive Summary

At CAGNY 2024, CEO Sue Nabi discussed Coty’s prestige fragrance strategy, including growing emphasis on ultra-premium offerings and continued focus on fashion-driven licenses, the same day the company announced a long-term fragrance licensing deal with Italian brand Etro.

You may also be interested in...

CoverGirl TikTok Post With 95M Views Demonstrates Coty’s Rising Influencer Clout – CEO Nabi

CoverGirl Simply Ageless Skin Perfector Essence foundation was the focus of a TikTok influencer post that attracted 95m views, showing the power of Coty’s rapidly expanding influencer game, says CEO Sue Nabi. Nabi discussed the firm’s influencer strategy and results in the firm’s fiscal 2024 second quarter presentation.

Natura Considers Avon Separation; LVMH Highlights Sephora Growth In 2023; Beauty News In Brief

Splitting off Avon as its own publicly traded company would unlock shareholder value and provide shareholders with greater visibility into the entities’ performance and potential, Natura says. Sephora sales fueled 20% reported growth in LVMH’s Selective Retailing business in 2023. More beauty news.

Coty Targeting White Space In Women’s Prestige Fragrances, Ultra-Premium Scents After Strong FY2023

Coty Inc. sees opportunities to grow its business in the $24bn prestige female fragrance market and strengthen its play in the ‘ultra-premium’ segment. The firm’s prestige fragrance sales rose 20% like-for-like in the fiscal 2023 fourth quarter ended 30 June, fueling overall net sales growth of 10% for the period.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts